Heart failure is an important medical disease and impacts millions of people throughout the world. In order to treat this problem, biomaterial injectable treatment injected into the myocardium of the failing LV are currently being developed. Through this treatment, the biomaterial material injections can reduce wall stresses during the cardiac remodeling process. By using computational techniques to analyze the effects of a treatment involving the injection of biomaterial material into the LV after MI, the material parameters of the hydrogel injections can be optimized. The results shows that the hydrogel injections could reduce the global average fiber stress and the transmural average stress seen from optimization. These results indicated...
Injectable hydrogels are a potential therapy for mitigating adverse left ventricular (LV) remodeling...
Every 40 seconds someone in the United States suffers from a myocardial infarction (MI) and 86% of t...
Biomaterial injectates are promising as a therapy for myocardial infarction to inhibit the adverse v...
Heart failure is an important medical disease and impacts millions of people throughout the world. I...
Heart failure (HF) is one of the leading causes of death and impacts millions of people throughout t...
Biomaterial injection is a potential new therapy for augmenting ventricular mechanics after myocardi...
Includes abstract.Includes bibliographical references.Cardiovascular diseases account for one third ...
Myocardial infarction, or heart attack, is the leading cause of mortality globally. Although the tre...
The canonical mechanism of wound healing is disrupted following a myocardial infarction (MI), manife...
Myocardial infarction, or heart attack, is the leading cause of mortality globally. Although the tre...
Left ventricular (LV) remodeling following myocardial infarction (MI) leads to maladaptive processes...
Following myocardial infarction (MI), left ventricular (LV) remodeling initiates a series of maladap...
The intramyocardial injection of biomaterials is an emerging therapy for myocardial infarction. Comp...
A recent trend has emerged that involves myocardial injection of biomaterials, containing cells or a...
Following myocardial infarction (MI), left ventricular (LV) remodeling initiates a series of maladap...
Injectable hydrogels are a potential therapy for mitigating adverse left ventricular (LV) remodeling...
Every 40 seconds someone in the United States suffers from a myocardial infarction (MI) and 86% of t...
Biomaterial injectates are promising as a therapy for myocardial infarction to inhibit the adverse v...
Heart failure is an important medical disease and impacts millions of people throughout the world. I...
Heart failure (HF) is one of the leading causes of death and impacts millions of people throughout t...
Biomaterial injection is a potential new therapy for augmenting ventricular mechanics after myocardi...
Includes abstract.Includes bibliographical references.Cardiovascular diseases account for one third ...
Myocardial infarction, or heart attack, is the leading cause of mortality globally. Although the tre...
The canonical mechanism of wound healing is disrupted following a myocardial infarction (MI), manife...
Myocardial infarction, or heart attack, is the leading cause of mortality globally. Although the tre...
Left ventricular (LV) remodeling following myocardial infarction (MI) leads to maladaptive processes...
Following myocardial infarction (MI), left ventricular (LV) remodeling initiates a series of maladap...
The intramyocardial injection of biomaterials is an emerging therapy for myocardial infarction. Comp...
A recent trend has emerged that involves myocardial injection of biomaterials, containing cells or a...
Following myocardial infarction (MI), left ventricular (LV) remodeling initiates a series of maladap...
Injectable hydrogels are a potential therapy for mitigating adverse left ventricular (LV) remodeling...
Every 40 seconds someone in the United States suffers from a myocardial infarction (MI) and 86% of t...
Biomaterial injectates are promising as a therapy for myocardial infarction to inhibit the adverse v...